Research Analysts’ Weekly Ratings Updates for UnitedHealth Group (UNH)

UnitedHealth Group (NYSE: UNH) recently received a number of ratings updates from brokerages and research firms:

• 10/11/2024 – UnitedHealth Group is now covered by analysts at KeyCorp. They set an “overweight” rating and a $675.00 price target on the stock.
• 10/10/2024 – UnitedHealth Group was upgraded by analysts at KeyCorp to a “strong-buy” rating.
• 10/1/2024 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
• 9/25/2024 – UnitedHealth Group was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 9/17/2024 – UnitedHealth Group was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 9/16/2024 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
• 9/10/2024 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.
• 9/9/2024 – UnitedHealth Group was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 8/30/2024 – UnitedHealth Group was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 8/21/2024 – UnitedHealth Group was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 8/19/2024 – UnitedHealth Group had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $591.00 price target on the stock.

UnitedHealth Group Trading Down 7.0 %

Shares of NYSE UNH traded down $42.37 during midday trading on Tuesday, reaching $563.03. The stock had a trading volume of 8,119,005 shares, compared to its average volume of 3,933,735. The firm has a market cap of $519.91 billion, a price-to-earnings ratio of 37.34, a price-to-earnings-growth ratio of 1.66 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The company’s 50 day moving average price is $584.39 and its 200 day moving average price is $532.15.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter in the prior year, the business earned $6.14 earnings per share. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. UnitedHealth Group’s dividend payout ratio is currently 55.70%.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction on Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

Institutional Trading of UnitedHealth Group

A number of large investors have recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group during the 3rd quarter worth approximately $27,000. Macroview Investment Management LLC grew its holdings in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 757.1% during the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares during the period. Bbjs Financial Advisors LLC bought a new position in UnitedHealth Group during the 2nd quarter valued at approximately $31,000. Finally, Global Wealth Strategies & Associates grew its position in shares of UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after buying an additional 32 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.